Clinical Trials Logo

Filter by:
NCT ID: NCT05174858 Completed - Tooth Avulsion Clinical Trials

Efficacy of a Collagen Hemostatic Dressing After Tooth Extraction

Start date: January 25, 2022
Phase: N/A
Study type: Interventional

This study is a multicentric randomised (2 groups, ratio 1:1) Post Market Clinical Follow-up trial. 38 subjects (teeth) requiring a simple tooth extraction or multiple tooth extraction on the same quadrant and taking curative or preventive antithrombotic treatment will be included (19 in each group). The aim of the study is to assess the efficacy of ETIK COLLAGENE (Topical hemostatic collagen-product) on the hemostasis (time to stop bleeding) after tooth extraction. The hemostasis is measured by assessing the presence of bleeding within the first 8 minutes post-extraction. Group 1: intra-alveolar placement of ETIK COLLAGENE immediately after tooth extraction. Group 2: the alveolus is left empty after tooth extraction (the use of ETIK COLLAGENE is delayed 8 minutes after tooth extraction, before suture). Subjects will be followed-up to 7 days.

NCT ID: NCT05174702 Completed - Surgery Clinical Trials

Assessment of the Ionizing Radiation Received During Percutaneous or Conventional Surgery of Hallux Valgus

RADUS
Start date: January 5, 2022
Phase:
Study type: Observational

To assess the average whole body radiation dose received by the surgeon, the operating team and the patient during hallux valgus surgery, depending on whether the surgery is percutaneous or conventional.

NCT ID: NCT05174533 Recruiting - Schizophrenia Clinical Trials

Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia

SCHIZO-CV
Start date: January 12, 2022
Phase:
Study type: Observational

Schizophrenia is a psychiatric disorder, affecting 600,000 patients in France. Patients with schizophrenia have life expectancy decrease from 10 to 20 years because of cardiovascular death. Cardiovascular risk factors are numerous: inadequate diet, smoking, alcohol consumption, diabetes, obesity. Primary prevention of cardiovascular risk in patients suffering from schizophrenia is difficult because of understaff in general practitioners and psychiatrists.

NCT ID: NCT05174403 Completed - Clinical trials for Spastic Paraplegia Type 5A, Recessive

Imaging Biomarkers in Spastic Paraplegia Type 5

SPIMA
Start date: January 28, 2022
Phase:
Study type: Observational

This is a research study aiming to identify imaging biomarkers in patients diagnosed with spastic paraplegia type 5 (SPG5)

NCT ID: NCT05173220 Recruiting - Clinical trials for Tracheal Intubation Morbidity

Impact of the Bougie on the Prehospital Setting Intubation Quality.

SMURIDS2
Start date: May 20, 2021
Phase:
Study type: Observational

Tracheal intubation in an out-of-hospital setting is a frequent and potentially difficult procedure. The risk of adverse events increases dramatically with the number of attempts. The failure rate of the first intubation attempt ranges from 5 to 32% and the risk factors are unclear. In recent study, the prevalence of a failed first intubation attempt was 31.4% [95% CI = 30.2-32.6] among 1546 patients managed in an out-of-hospital setting. In this multicenter study, our center (N=462) had a rate of 36% of failure of the first attempt. Seven variables were independently associated with a failed first intubation attempt. Some of the associated factors can be improved (operator training and experience), but most cannot. Moreover some of them can not be anticipated in this context. A randomized control trial performed in an emergency department and a prospective, observational, pre-post study design showed that systematic use of a bougie during the first intubation attempt improved the success rate. Our objective is to measure the impact of a modification of our intubation modalities introducing the incitation of the use of the bougie on the first intubation attempt in the prehospital setting.

NCT ID: NCT05173116 Withdrawn - Emergencies Clinical Trials

Evaluation of the API-VIGIE Monitoring System: Program to Reduce Emergency Visits for Severe Paroxysmal Alcoholism

EVAL-APIVIGIE
Start date: February 2022
Phase:
Study type: Observational

The study was designed to evaluate the APIVIGIE program use at CH d'Arras. The objective of this program is to reduce repeated visits by the same patient to the emergency room for Alcoholism Severe Paroxysmal

NCT ID: NCT05172986 Completed - Prostate Cancer Clinical Trials

Enhanced Recovery Program After a Robotic-assisted Surgery (RAAC) of Radical Prostatectomy. PROSTA-RAAC

PROSTA-RAAC
Start date: October 27, 2021
Phase: N/A
Study type: Interventional

There are few published data on the benefit of Enhanced recovery program in radical prostatectomy in the management of localized prostate cancer. All the studies available on the subject are retrospective (1-3). This randomized comparative study is proposed in order to compare in a homogeneous population (place and time) the interest of RAAC specifically in this surgery.

NCT ID: NCT05172778 Recruiting - Lupus Anticoagulant Clinical Trials

Observational Study of the Performance of Cephen Reagents in the Context of Research Into Lupus Anticoagulants

LA
Start date: July 30, 2021
Phase:
Study type: Observational

Lupus anticoagulants (are antiphospholipid antibodies (PSA), the screening of which is done by demonstrating prolongation of coagulation times corrected by the intake of phospholipids (PL). Learned societies (ISTH, CLSI) thus recommend, for the research of LA, to carry out initially two screening tests with a low concentration in PL: a time of diluted Russell viper venom (DRVVT) as well as a time activated partial thromboplastin (TCA). If one of these screening tests is positive, it is recommended to perform a second confirmation test using the same principle (DRVVT or TCA) and containing a higher concentration of PL. The current LA screening method at the Hematology Laboratory of Strasbourg University Hospital includes: a pair of DRVVT screening / confirmation (STA-Staclot DRVV Screen and Confirm, Diagnostica Stago, France) and a screening TCA (PTT-A , Diagnostica Stago, France). This study aims to compare with the current method of the investigators a pair of TCA screening / confirmation (Cephen LS / Cephen, Hyphen Biomed, France).

NCT ID: NCT05172713 Recruiting - Colorectal Cancer Clinical Trials

Outcomes of Patients Who Had an Incomplete Colonoscopy After a Positive Fecal Immunological Test

ColonoScopy
Start date: January 16, 2021
Phase:
Study type: Observational

In France, colorectal cancer (CRC) is the second leading cause of cancer death. Its organized screening (Organized ColoRectal Cancer Screening: DOCCR), now carried out by immunological test for occult blood in the stool, has proven its effectiveness. When the immunological test is positive, the Haute Autorité de Santé recommends a total colonoscopy. In 5 to 10% of cases, this colonoscopy is incomplete. The renewal of the endoscopic procedure or the performance of additional second-line examinations are then recommended. At present, however, the respective place of second-line examinations to be performed in this situation is not the subject of specific and validated recommendations.

NCT ID: NCT05172622 Recruiting - Diabetes Mellitus Clinical Trials

Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 in Healthy Subjects

Start date: November 24, 2020
Phase: Phase 1
Study type: Interventional

Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 after Oral Administration in Healthy Male Caucasian Subjects